Literature DB >> 23463341

Lipopolysaccharide-binding protein: a potential marker of febrile urinary tract infection in childhood.

Evanthia A Tsalkidou1, Emmanouel Roilides, Stefanos Gardikis, Gregory Trypsianis, Alexandros Kortsaris, Athanasios Chatzimichael, Ioannis Tentes.   

Abstract

BACKGROUND: Urinary tract infections (UTIs) are encountered frequently in children, and their early diagnosis and treatment are important. This study evaluates the diagnostic value of serum concentrations of lipopolysaccharide-binding protein (LBP), an acute-phase protein, in children with febrile UTI and compares it to those of the total white blood cell count (WBC), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), procalcitonin (PCT), and interleukin-6 (IL-6).
METHODS: The study population comprised 77 consecutive patients with a first-episode febrile UTI (33 boys) with a median age of 11 months [interquartile range (IQR), 5.5-33 months], 21 healthy controls (11 boys) with a median age of 10 months (IQR, 5-20.5 months) and 58 febrile controls with a fever due to other causes (28 boys) with a median age of 12.5 months (IQR, 7-30 months). LBP, IL-6, PCT, and CRP were measured for both patients and control groups.
RESULTS: The serum levels of LBP (p  <  0.001), CRP (p  <  0.001), PCT (p  =  0.001), IL-6 (p  =  0.002), ESR (p  =  0.020), and WBC (p  <  0.001) were higher in patients with febrile UTI than in the healthy and febrile control groups. The LPB cut-off value for best sensitivity and specificity in patients with febrile UTI was >43.23 mg/l. Furthermore, the area under the receiver operating characteristic curve was significantly greater for LBP than for CRP (p  =  0.014), PCT (p  <  0.001), ESR (p  <  0.001), WBC (p  =  0.002) and IL-6 (p  =  0.006).
CONCLUSIONS: The results of this study suggest that the serum LBP concentration constitutes a reliable biologic marker for the diagnosis of a febrile UTI in children.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23463341     DOI: 10.1007/s00467-013-2432-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  23 in total

1.  Antibiotic resistance patterns in children hospitalized for urinary tract infections.

Authors:  Stephanie A Lutter; Melissa L Currie; Lindsay B Mitz; Larry A Greenbaum
Journal:  Arch Pediatr Adolesc Med       Date:  2005-10

2.  Cytokine profiles of pediatric patients treated with antibiotics for pyelonephritis: potential therapeutic impact.

Authors:  K Kassir; O Vargas-Shiraishi; F Zaldivar; M Berman; J Singh; A Arrieta
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.

Authors:  Jun Kohara; Naoko Tsuneyoshi; Jean-François Gauchat; Masao Kimoto; Kenji Fukudome
Journal:  Protein Expr Purif       Date:  2006-06-06       Impact factor: 1.650

4.  Usefulness of procalcitonin and C-reactive protein rapid tests for the management of children with urinary tract infection.

Authors:  A Gervaix; A Galetto-Lacour; T Gueron; L Vadas; S Zamora; S Suter; E Girardin
Journal:  Pediatr Infect Dis J       Date:  2001-05       Impact factor: 2.129

5.  Urinary interleukin-6 and interleukin-8 in children with urinary tract infection.

Authors:  B A Jantausch; R O'Donnell; B L Wiedermann
Journal:  Pediatr Nephrol       Date:  2000-12       Impact factor: 3.714

6.  Procalcitonin: a marker of severity of acute pyelonephritis among children.

Authors:  Paolo Pecile; Elisabetta Miorin; Carla Romanello; Edmondo Falleti; Francesca Valent; Francesco Giacomuzzi; Alfred Tenore
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

7.  Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.

Authors:  Maja Pavcnik-Arnol; Sergej Hojker; Metka Derganc
Journal:  Intensive Care Med       Date:  2004-05-04       Impact factor: 17.440

8.  Procalcitonin increase after endotoxin injection in normal subjects.

Authors:  P Dandona; D Nix; M F Wilson; A Aljada; J Love; M Assicot; C Bohuon
Journal:  J Clin Endocrinol Metab       Date:  1994-12       Impact factor: 5.958

9.  Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children.

Authors:  Maja Pavcnik-Arnol; Sergej Hojker; Metka Derganc
Journal:  Intensive Care Med       Date:  2007-04-05       Impact factor: 17.440

10.  Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.

Authors:  Nicolas W J Schröder; Holger Heine; Christian Alexander; Maria Manukyan; Jana Eckert; Lutz Hamann; Ulf B Göbel; Ralf R Schumann
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  5 in total

1.  The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.

Authors:  Tamer Sallam; Ayaka Ito; Xin Rong; Jason Kim; Caroline van Stijn; Brian T Chamberlain; Michael E Jung; Lily C Chao; Marius Jones; Thomas Gilliland; XiaoHui Wu; Grace L Su; Rajendra K Tangirala; Peter Tontonoz; Cynthia Hong
Journal:  J Lipid Res       Date:  2014-03-26       Impact factor: 5.922

2.  Lipopolysaccharide-binding protein: a valuable biomarker in the differentiation between periprosthetic joint infection and aseptic loosening?

Authors:  Max J Friedrich; Thomas M Randau; Matthias D Wimmer; Ben Reichert; Dominik Kuberra; Birgit Stoffel-Wagner; Dieter C Wirtz; Sascha Gravius
Journal:  Int Orthop       Date:  2014-05-15       Impact factor: 3.075

3.  Detection of PCT and urinary β2 -MG enhances the accuracy for localization diagnosing pediatric urinary tract infection.

Authors:  Jian Fang; Jiangwei Luan; Gaohong Zhu; Chang Qi; Dandan Wang
Journal:  J Clin Lab Anal       Date:  2016-11-01       Impact factor: 2.352

4.  Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis.

Authors:  Takashi Himoto; Shuhei Yamamoto; Kaho Morimoto; Satoshi Tada; Shima Mimura; Koji Fujita; Joji Tani; Asahiro Morishita; Tsutomu Masaki
Journal:  J Clin Lab Anal       Date:  2021-10-08       Impact factor: 2.352

5.  Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.

Authors:  Fabiana Azevedo Voorwald; Fabio Albuquerque Marchi; Rolando Andre Rios Villacis; Carlos Eduardo Fonseca Alves; Gilson Hélio Toniollo; Renee Laufer Amorim; Sandra Aparecida Drigo; Silvia Regina Rogatto
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.